4/25
06:24 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
4/25
06:24 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
4/24
10:12 am
dmra
Rating for DMRA
Low
Report
Rating for DMRA
4/24
10:12 am
dmra
Rating for DMRA
Low
Report
Rating for DMRA
4/24
09:00 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
4/24
09:00 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
4/23
04:20 pm
dmra
Damora Therapeutics initiated with an Outperform at RBC Capital
Low
Report
Damora Therapeutics initiated with an Outperform at RBC Capital
4/23
04:20 pm
dmra
Damora Therapeutics initiated with an Outperform at RBC Capital
Low
Report
Damora Therapeutics initiated with an Outperform at RBC Capital
3/25
01:03 pm
dmra
Rating for DMRA
Low
Report
Rating for DMRA